• 1
    McMurray RW. Prolactin and systemic lupus erythematosus. Ann Med Interne (Paris) 1996; 147:253258.
  • 2
    Allen SH, Sharp GC, Wang G et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996; 5:3037.
  • 3
    Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratios are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. Br J Rheumatol 1996; 23:476481.
  • 4
    Miranda JM, Priet RE, Panigua R et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 1998; 7:387391.
  • 5
    Orbach H, Zandman-Goddard G, Boaz M et al. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol 2012; 42:189198.
  • 6
    Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev 2012; 11:A465470.
  • 7
    Karimifar M, Tahmasebi A, Bonakdar ZS, Purajam S. Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus. Rheumatol Int 2011; doi:10.1007/s00296-011-2211-5.
  • 8
    Blanco-Fabela F, Quintal-Alvarez G, Leaños-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol 1999; 26:5559.
  • 9
    Saha S, Tieng A, Pepeljugoski KP, Zandamn-Goddard G, Peeva E. Prolactin, systemic lupus erythematosus, and autoreactive B cell: lessons learn from murine models. Clin Rev Allergy Immunol 2011; 40:815.
  • 10
    McMurray R, Keisler D, Izui S, Walker S. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994; 71:338343.
  • 11
    Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naïve B cell repertoire. J Clin Invest 2003; 11:275283.
  • 12
    Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 2009; 60:17431752.
  • 13
    Morel L, Mohan C, Yu Y et al. Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm Genome 1999; 10:176181.
  • 14
    Peeva E, Gonzalez J, Hicks R, Diamond B. Lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 Mice. J Immunol 2006; 177:14011405.
  • 15
    Maraskovsky E, Brasel K, Teepe M et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996; 84:19531962.
  • 16
    Dranoff G, Jaffee E, Lazenby A et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte–macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor. Proc Natl Acad Sci USA 1993; 90:35393543.
  • 17
    Van Elsas A, Hurwitz AA, Allison J. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-production vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 1999; 190:355363.
  • 18
    Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in mature splenic B cell development. J Immunol 2002; 168:21012110.
  • 19
    Vossenkamper A, Luttalo PM, Spencer J. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol 2012; 167:714.
  • 20
    Mohan C, Yu Y, Morel L, Yang P, Wakeland EK. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999; 162:64926502.
  • 21
    Sobel ES, Morel L, Baert R, Mohan C, Schiffenbauer J, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by Non-T Cells. J Immunol 2002; 69:40254032.
  • 22
    Zhu J, Liu XB, Xie C et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 2005; 115:18691878.
  • 23
    Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 2000; 106:13731379.
  • 24
    Liu K, Li QZ, Yu Y et al. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun 2007; 8:634645.
  • 25
    Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:13741377.
  • 26
    Grimaldi CM, Hicks R, Betty Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol 2005; 174:17751781.
  • 27
    Ding C, Yan J. Regulation of autoreactive B cells: checkpoints and activation. Arch Immunol Ther Exp (Warsz) 2007; 55:8389.
  • 28
    Von Boehmer H, Melchers F. Check points in lymphocytes development and autoimmunune disease. Nat Immunol 2010; 11:1420.
  • 29
    Wykes M, Macpherson G. Dendritic cell–B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 2000; 100:13.
  • 30
    Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2003; 21:7177.
  • 31
    Caux C, Massacrier C, Vanbervliet B et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte–macrophage colony-stimulating factor plus tumor necrosis factor-α. II. Functional analysis. Blood 1997; 90:14581470.
  • 32
    Dubois B, Massacrier C, Vanbervliet B et al. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 1998; 161:22232231.
  • 33
    Hostmann A, Jacobi AM, Mei H, Hiepe F, Dörner T. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus. Lupus 2008; 17:10641069.
  • 34
    Dörner T, Lipsky PE. Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 2004; 13:283289.
  • 35
    Vigetti D, Genasetti A, Karousou E, Viola M, Moretto P, Clerici M. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-κB (NF-κB) pathway. J. Chem Biol 2010; 285:2463924645.
  • 36
    Tang T, Rosenkranz A, Assmann K et al. A role for Mac-1 (CD11b/CD1 in FcgR interactions in vivo: Mac-1 deficiency abrogates sustained neutrophil adhesion and proteinuria in Fc-dependent anti-glomerular basement membrane nephritis. J Exp Med 1997; 186:18531863.
  • 37
    Westerhuis R, van Straaten SC, van Dixhoorn M et al. Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis. Am J Pathol 2000; 156:303310.
  • 38
    Jacob CO, Zhu J, Armstrong DL et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci USA 2009; 106:62566261.
  • 39
    Sawalha AH. Xq28 and lupus: IRAK1 or MECP2? Proc Natl Acad Sci USA 2009; 106:E62.
  • 40
    Colonna L, Dinnall JA, Shivers DK, Frisoni L, Caricchio R, Gallucci S. Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res Ther 2006; 8:111.
  • 41
    Jego G, Pascual V, Palucka AK, Banchereau J. Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 2005; 8:124139.
  • 42
    Kaneko Y, Hirose S, Abe M, Yagita H, Okumura K, Shirai T. CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus. Eur J Immunol 1996; 26:30613065.
  • 43
    Tokunaga M, Fujii K, Saito K et al. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab. Rheumatology (Oxf) 2005; 44:176182.